JAZZ vs WK · P/E 1988, rev $2.28B vs rev $502.6M
Jazz Pharmaceuticals PLC (JAZZ) versus Workiva Inc (WK) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Workiva Inc (WK) is a software - application company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported WK revenue for 2026-06-30 was $502.6M. Net income was $32.4M. WK currently screens at market cap $3.86B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. WK currently screens at market cap $3.86B.
Not investment advice. Open the JAZZ and WK stock pages for the full models.
Not investment advice.